REXR (REXR)

$8.0B
Market Cap
38.9
P/E Ratio
1.25
Beta
5.20%
Dividend Yield
Piotroski 6/9Altman Z 1.4 DistressBeneish M -2.50 CleanROIC−WACC -7.9%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 1.4.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics suggest a capital allocation challenge where the company's return on invested capital of 2.1% significantly underperforms its weighted average cost of capital at 10.0%, resulting in a negative spread that erodes intrinsic value despite robust profitability metrics. While DuPont decomposition reveals strong operating leverage with net margins expanding to 21.1% and gross margins holding steady near 77%, this is offset by extremely low asset turnover of just 0.08x, indicating inefficient capital deployment or heavy reliance on equity financing reflected in a modest multiplier of 1.43x. Credit risk indicators present a dichotomy; the Altman Z-Score of 1.4 flags potential distress territory, yet the Beneish M-Score of -2.50 and strong Piotroski F-Score of 6/9 collectively signal low earnings manipulation risk and solid financial health relative to peers.

Valuation metrics appear stretched when weighed against implied growth expectations and fair value calculations. The current price-to-earnings ratio of 38.9x trades at a substantial premium, suggesting the market is pricing in significantly higher future performance than currently realized by revenue growing only 7.1% year-over-year. This disconnect is starkly highlighted by the DCF model, which anchors fair value at $9 per share, implying that current market levels may not be fully supported by projected cash flows given the negative ROIC-WACC spread. The high multiple suggests investors are betting on a future turnaround in capital efficiency or margin expansion that has yet to materialize in the bottom line.

Recent insider activity adds another layer of caution to the risk-reward profile, with $329,554 net selling recorded over the last 90 days, potentially indicating management skepticism regarding near-term prospects despite the strong balance sheet quality indicated by low manipulation scores. The combination of distressed-level solvency metrics alongside aggressive valuation creates a scenario where downside protection is limited if asset turnover fails to improve, while upside remains contingent on successful operational restructuring rather than organic margin growth alone.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8%10%12%
2%$14$7$2
3%$18$9$4
4%$25$12$5

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $9 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
1.4
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.50
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

77.3%
Gross Margin
21.1%
Net Margin
2.1%
ROIC
10.0%
WACC
ROIC − WACC Spread: -7.9%— Negative spread.
+7.1%
Revenue Growth (YoY)
-22.6%
Earnings Growth (YoY)
208.7M
Free Cash Flow
202%
FCF Payout Ratio

⚠️ Dividend consumes >80% of FCF — sustainability risk.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

21.1%
Net Profit Margin
NI ÷ Revenue
×
0.08x
Asset Turnover
Revenue ÷ Assets
×
1.43x
Equity Multiplier
Assets ÷ Equity
=
2.4%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

0.43x
Debt / Equity
1.22x
Current Ratio
3.1x
Interest Coverage
5.0x
Net Debt / EBITDA
1.89%
FCF Yield
616.2M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-329,554
Net Selling
3
Buy Transactions
1
Sale Transactions
2026-03-17FRANKEL MICHAEL SSold 2/8 qtrsSale$816,358
2026-02-27STOCKERT DAVID PAULBuy$186,958
2026-02-27FITZMAURICE MICHAEL P.Buy$99,508
2026-02-27CLARK LAURA ESold 1/8 qtrsBuy$200,338
2025-12-31STOCKERT DAVID PAULGrant1,829 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✗ Miss
Est: $0.28
Act: $0.24
-13.1%
Q3
✓ Beat
Est: $0.27
Act: $0.29
+9.2%
Q2
✗ Miss
Est: $0.30
Act: $0.25
-17.8%
Q1
✓ Beat
Est: $0.19
Act: $0.29
+53.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

35.0
Forward P/E
PEG Ratio
0.93
Price/Book
3M
Avg Volume
$44.38
52W High
$29.68
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$780M
Tracked Passive Exposure
8
ETFs Holding REXR
0.16%
Avg Weight in ETFs
$478B
Total ETF AUM

When investors buy or sell ETFs like MDYV or VNQ, the fund manager is mechanically forced to buy or sell REXR shares regardless of REXR's individual fundamentals. We estimate $780M of passive capital is structurally linked to REXR through 8 tracked ETFs. Passive flows have a limited but growing influence on REXR's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in REXR to visualize passive redemption contagion across ETFs and collateral stocks.

REXR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
REXREpicenterVBETFVXFETFVNQETFVRTPXUnknownWELLLow RiskPLDMed RiskEQIXMed RiskAMTHigh Risk
REXR Price Drop (%)0

If REXR (REXR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Vanguard Real Estate II Index Fund Institutional Plus Shares (VRTPX) as the most exposed collateral stock, sharing 1 ETFs with REXR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 11 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

REXR Ownership Dynamics

Ticker
REXR

Float lock-up computed from 11 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

REXR Capital Efficiency

How efficiently does REXR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$209M
EBITDA
$616M
FCF Conversion
34%
Reinvestment Rate
66%
34% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
2.1%
ROIC − WACC Spread
-7.9%

REXR converts 34% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 66% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-7.9%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-0519,205$35.14$674,863.7
2026-04-293,362$35.84$120,494.08
2026-04-276,325$35.47$224,347.75
2026-04-092$34.23$68.46
2026-04-061,114$33.12$36,895.68
2026-03-319,507$32.62$310,118.34
2026-03-2428$34.60$968.8
2026-03-232,946$33.97$100,075.62
2026-03-1931$34.29$1,062.99
2026-03-17271$34.82$9,436.22
2026-03-16224,978$34.47$7.8M
2026-03-096,675$36.03$240,500.25
2026-03-03920$37.65$34,638
2026-02-276,334$37.88$239,931.92
2026-02-263,000$37.35$112,050
2026-02-25690$37.14$25,626.6
2026-02-2316,296$37.66$613,707.36
2026-02-2038,835$37.12$1.4M
2026-02-13689$36.89$25,417.21
2026-02-0566$41.39$2,731.74
2026-02-0426,043$40.56$1.1M
2026-02-034,406$40.29$177,517.74
2026-02-025,540$40.53$224,536.2
2026-01-1595,187$40.95$3.9M
2026-01-074,374$38.82$169,798.68
2025-12-22480$41.17$19,761.6
2025-12-182,046$41.20$84,295.2
2025-12-08448,270$40.73$18.3M
2025-11-25200$40.82$8,164
2025-11-21246$40.26$9,903.96

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare REXR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.